FDA Drug Application (021845) for REVATIO by PFIZER

Back to FDA Applications sponsored by PFIZER

Application Number021845
Product Number001
FormTABLET;ORAL
DosageEQ 20MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREVATIO
Active IngredientSILDENAFIL CITRATE

Active IngredientCount
List of drugs with Active Ingredient SILDENAFIL CITRATE3


Back to FDA Applications sponsored by PFIZER